David Roman
Stock Analyst at Goldman Sachs
(1.98)
# 3,016
Out of 4,898 analysts
44
Total ratings
37.5%
Success rate
-2.4%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Initiates: Buy | $29 | $17.55 | +65.24% | 1 | Jul 1, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $94 → $104 | $97.34 | +6.84% | 3 | Jun 4, 2025 | |
| BBNX Beta Bionics | Initiates: Neutral | $16 | $12.83 | +24.71% | 1 | May 30, 2025 | |
| PODD Insulet | Initiates: Buy | $380 | $292.01 | +30.13% | 1 | May 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $80 → $50 | $61.55 | -18.77% | 3 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $120 → $104 | $93.86 | +10.80% | 2 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Buy | $13 → $10 | $8.27 | +20.92% | 4 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $94 → $82 | $74.45 | +10.14% | 3 | May 1, 2025 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $24 → $23 | $15.43 | +49.06% | 2 | Apr 16, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $138 → $154 | $132.03 | +16.64% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $15.75 | +52.38% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $74.07 | -4.14% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $43.97 | +25.09% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $42 | $28.53 | +47.21% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $91 → $124 | $138.91 | -10.73% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $391.46 | +9.08% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $78.28 | +14.97% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $104.33 | -13.74% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $516.44 | -3.18% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $177.09 | +54.72% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $89.73 | -7.50% | 1 | May 30, 2024 |
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $17.55
Upside: +65.24%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $97.34
Upside: +6.84%
Beta Bionics
May 30, 2025
Initiates: Neutral
Price Target: $16
Current: $12.83
Upside: +24.71%
Insulet
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $292.01
Upside: +30.13%
Doximity
May 21, 2025
Maintains: Neutral
Price Target: $80 → $50
Current: $61.55
Upside: -18.77%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $93.86
Upside: +10.80%
Teladoc Health
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $8.27
Upside: +20.92%
GE HealthCare Technologies
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $74.45
Upside: +10.14%
Kestra Medical Technologies
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $15.43
Upside: +49.06%
Abbott Laboratories
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $132.03
Upside: +16.64%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $15.75
Upside: +52.38%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $74.07
Upside: -4.14%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $43.97
Upside: +25.09%
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $28.53
Upside: +47.21%
Feb 24, 2025
Maintains: Neutral
Price Target: $91 → $124
Current: $138.91
Upside: -10.73%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $391.46
Upside: +9.08%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $78.28
Upside: +14.97%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $104.33
Upside: -13.74%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $516.44
Upside: -3.18%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $177.09
Upside: +54.72%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $89.73
Upside: -7.50%